René Fouodjio


Rene Fouodjio joined StatGen in Jan 2015 as Statistical Programmer. He is in charge of the association analyses between genetic variation and response to cardiovascular drugs. He has prior experience in analysing preclinical data using SAS software from Charles River Laboratories. He has also worked at the McGill Health Center as research statistician in health-related research. Rene has over 10 years' experience in different components of SAS software and is a SAS Certified Advanced Programmer for SAS9. Rene received his Master in statistics from Sherbrooke University.

Selected publications

  • A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure. de Denus, Simon, Dubé, Marie-Pierre, Fouodjio, René, Huynh, Thao, LeBlanc, Marie-Hélène, Lepage, Serge, Sheppard, Richard, Giannetti, Nadia, Lavoie, Joël, Mansour, Asmaa and others. Pharmacogenomics 2018; 7: 599-612. [BibTeX]
  • CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction. de Denus, Simon, Rouleau, Jean L, Mann, Douglas L, Huggins, Gordon S, Pereira, Naveen L, Shah, Svati H, Cappola, Thomas P, Fouodjio, René, Mongrain, Ian and Dubé, Marie-Pierre. The pharmacogenomics journal 2018; 2: 232-237. [BibTeX]
  • Genotype-dependent effects of dalcetrapib on cholesterol efflux and inflammation: concordance with clinical outcomes. Tardif, Jean-Claude, Rhainds, David, Brodeur, Mathieu, Feroz Zada, Yassamin, Fouodjio, René, Provost, Sylvie, Boulé, Marie, Alem, Sonia, Grégoire, Jean C, L’Allier, Philippe L and others. Circulation: Cardiovascular Genetics 2016; 4: 340-348. [BibTeX]